Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Fo

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,795	204 Pages	Transparency Market Research Pvt. Ltd.	May, 2022	TNPR17326544

Best Price Guarantee
Price	from $5,795
Length	204 Pages
Publisher	Transparency Market Research Pvt. Ltd.
Published Date	May, 2022
SKU	TNPR17326544

Electrophysiology Devices Market (Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Microport Scientific Corporation
Biotronik SE & Co.KG
Koninklijke Philips N.V.
Medtronic plc
GE Healthcare
Boston Scientific Corporation
Biosense Webster, Inc.
Nihon Kohden Corporation
F. Siemens AG
Acutus Medical, Inc.
Abbott Laboratories
Other Players

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first) Value - 6.7

Forecast Year (last) Value - 14.8

CAGR % - 0.082

Currency - US$ Bn

1. Preface: 1.1. Market Definition and Scope; 1.2. Market Segmentation; 1.3. Key Research Objectives; 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Electrophysiology Devices Market
4. Market Overview: 4.1. Introduction; 4.1.1. Product Type Definition; 4.1.2. Industry Evolution / Developments; 4.2. Overview; 4.3. Market Dynamics; 4.3.1. Drivers; 4.3.2. Restraints; 4.3.3. Opportunities; 4.4. Global Electrophysiology Devices Market Analysis and Forecast, 2017–2031; 4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights: 5.1. Technological advancements; 5.2. Key Industry Events; 5.3. COVID-19 Impact
6. Global Electrophysiology Devices Market Analysis and Forecast, by Product Type: 6.1. Introduction & Definition; 6.2. Key Findings / Developments; 6.3. Market Value Forecast, by Product Type, 2017–2031; 6.3.1. Electrophysiology Ablation Catheters; 6.3.1.1. Cryoablation Electrophysiology Catheters; 6.3.1.2. Radiofrequency Ablation Catheters; 6.3.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 6.3.1.2.2. Conventional Radiofrequency Ablation Catheters; 6.3.1.3. Laser Ablation Systems; 6.3.1.4. Microwave Ablation Systems; 6.3.1.5. Navigational Advanced Mapping Accessories; 6.3.2. Electrophysiology Diagnostic Catheters; 6.3.2.1. Conventional Electrophysiology Diagnostic Catheters; 6.3.2.1.1. Steerable Diagnostic Catheters; 6.3.2.1.2. Fixed Diagnostic Catheters; 6.3.2.2. Advanced Electrophysiology Diagnostic Catheters; 6.3.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 6.3.3. Electrophysiology Laboratory Devices; 6.3.4. Access Devices; 6.3.5. Others; 6.4. Market Attractiveness Analysis, by Product Type
7. Global Electrophysiology Devices Market Analysis and Forecast, by End-user: 7.1. Introduction & Definition; 7.2. Key Findings / Developments; 7.3. Market Value Forecast, by End-user, 2017–2031; 7.3.1. Hospitals; 7.3.2. Diagnostic Centers; 7.3.3. Clinics; 7.3.4. Others; 7.4. Market Attractiveness Analysis, by End-user
8. Global Electrophysiology Devices Market Analysis and Forecast, by Indication: 8.1. Introduction & Definition; 8.2. Key Findings / Developments; 8.3. Market Value Forecast, by Indication, 2017–2031; 8.3.1. Atrial Fibrillation (AF); 8.3.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 8.3.3. Wolff-Parkinson-White Syndrome (WPW); 8.3.4. Atrial Flutter; 8.3.5. Others; 8.4. Market Attractiveness Analysis, by Indication
9. Global Electrophysiology Devices Market Analysis and Forecast, by Region: 9.1. Key Findings; 9.2. Market Value Forecast, by Region; 9.2.1. North America; 9.2.2. Europe; 9.2.3. Asia Pacific; 9.2.4. Latin America; 9.2.5. Middle East & Africa; 9.3. Market Attractiveness Analysis, by Region
10. North America Electrophysiology Devices Market Analysis and Forecast: 10.1. Introduction; 10.1.1. Key Findings; 10.2. Market Value Forecast, by Product Type, 2017–2031; 10.2.1. Electrophysiology Ablation Catheters; 10.2.1.1. Cryoablation Electrophysiology Catheters; 10.2.1.2. Radiofrequency Ablation Catheters; 10.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 10.2.1.2.2. Conventional Radiofrequency Ablation Catheters; 10.2.1.3. Laser Ablation Systems; 10.2.1.4. Microwave Ablation Systems; 10.2.1.5. Navigational Advanced Mapping Accessories; 10.2.2. Electrophysiology Diagnostic Catheters; 10.2.2.1. Conventional Electrophysiology Diagnostic Catheters; 10.2.2.1.1. Steerable Diagnostic Catheters; 10.2.2.1.2. Fixed Diagnostic Catheters; 10.2.2.2. Advanced Electrophysiology Diagnostic Catheters; 10.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 10.2.3. Electrophysiology Laboratory Devices; 10.2.4. Access Devices; 10.2.5. Others; 10.3. Market Value Forecast, by End-user, 2017–2031; 10.3.1. Hospitals; 10.3.2. Diagnostic Centers; 10.3.3. Clinics; 10.3.4. Others; 10.4. Market Value Forecast, by Indication, 2017–2031; 10.4.1. Atrial Fibrillation (AF); 10.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 10.4.3. Wolff-Parkinson-White Syndrome (WPW); 10.4.4. Atrial Flutter; 10.4.5. Others; 10.5. Market Value Forecast, by Country, 2017–2031; 10.5.1. U.S.; 10.5.2. Canada; 10.6. Market Attractiveness Analysis; 10.6.1. By Product Type; 10.6.2. By End-user; 10.6.3. By Indication; 10.6.4. By Country
11. Europe Electrophysiology Devices Market Analysis and Forecast: 11.1. Introduction; 11.1.1. Key Findings; 11.2. Market Value Forecast, by Product Type, 2017–2031; 11.2.1. Electrophysiology Ablation Catheters; 11.2.1.1. Cryoablation Electrophysiology Catheters; 11.2.1.2. Radiofrequency Ablation Catheters; 11.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 11.2.1.2.2. Conventional Radiofrequency Ablation Catheters; 11.2.1.3. Laser Ablation Systems; 11.2.1.4. Microwave Ablation Systems; 11.2.1.5. Navigational Advanced Mapping Accessories; 11.2.2. Electrophysiology Diagnostic Catheters; 11.2.2.1. Conventional Electrophysiology Diagnostic Catheters; 11.2.2.1.1. Steerable Diagnostic Catheters; 11.2.2.1.2. Fixed Diagnostic Catheters; 11.2.2.2. Advanced Electrophysiology Diagnostic Catheters; 11.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 11.2.3. Electrophysiology Laboratory Devices; 11.2.4. Access Devices; 11.2.5. Others; 11.3. Market Value Forecast, by End-user, 2017–2031; 11.3.1. Hospitals; 11.3.2. Diagnostic Centers; 11.3.3. Clinics; 11.3.4. Others; 11.4. Market Value Forecast, by Indication, 2017–2031; 11.4.1. Atrial Fibrillation (AF); 11.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 11.4.3. Wolff-Parkinson-White Syndrome (WPW); 11.4.4. Atrial Flutter; 11.4.5. Others; 11.5. Market Value Forecast, by Country/Sub-region, 2017–2031; 11.5.1. Germany; 11.5.2. U.K.; 11.5.3. France; 11.5.4. Spain; 11.5.5. Italy; 11.5.6. Rest of Europe; 11.6. Market Attractiveness Analysis; 11.6.1. By Product Type; 11.6.2. By End-user; 11.6.3. By Indication; 11.6.4. By Country/Sub-region
12. Asia Pacific Electrophysiology Devices Market Analysis and Forecast: 12.1. Introduction; 12.1.1. Key Findings; 12.2. Market Value Forecast, by Product Type, 2017–2031; 12.2.1. Electrophysiology Ablation Catheters; 12.2.1.1. Cryoablation Electrophysiology Catheters; 12.2.1.2. Radiofrequency Ablation Catheters; 12.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 12.2.1.2.2. Conventional Radiofrequency Ablation Catheters; 12.2.1.3. Laser Ablation Systems; 12.2.1.4. Microwave Ablation Systems; 12.2.1.5. Navigational Advanced Mapping Accessories; 12.2.2. Electrophysiology Diagnostic Catheters; 12.2.2.1. Conventional Electrophysiology Diagnostic Catheters; 12.2.2.1.1. Steerable Diagnostic Catheters; 12.2.2.1.2. Fixed Diagnostic Catheters; 12.2.2.2. Advanced Electrophysiology Diagnostic Catheters; 12.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 12.2.3. Electrophysiology Laboratory Devices; 12.2.4. Access Devices; 12.2.5. Others; 12.3. Market Value Forecast, by End-user, 2017–2031; 12.3.1. Hospitals; 12.3.2. Diagnostic Centers; 12.3.3. Clinics; 12.3.4. Others; 12.4. Market Value Forecast, by Indication, 2017–2031; 12.4.1. Atrial Fibrillation (AF); 12.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 12.4.3. Wolff-Parkinson-White Syndrome (WPW); 12.4.4. Atrial Flutter; 12.4.5. Others; 12.5. Market Value Forecast, by Country/Sub-region, 2017–2031; 12.5.1. China; 12.5.2. Japan; 12.5.3. India; 12.5.4. Australia & New Zealand; 12.5.5. Rest of Asia Pacific; 12.6. Market Attractiveness Analysis; 12.6.1. By Product Type; 12.6.2. By End-user; 12.6.3. By Indication; 12.6.4. By Country/Sub-region
13. Latin America Electrophysiology Devices Market Analysis and Forecast: 13.1. Introduction; 13.1.1. Key Findings; 13.2. Market Value Forecast, by Product Type, 2017–2031; 13.2.1. Electrophysiology Ablation Catheters; 13.2.1.1. Cryoablation Electrophysiology Catheters; 13.2.1.2. Radiofrequency Ablation Catheters; 13.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 13.2.1.2.2. Conventional Radiofrequency Ablation Catheters; 13.2.1.3. Laser Ablation Systems; 13.2.1.4. Microwave Ablation Systems; 13.2.1.5. Navigational Advanced Mapping Accessories; 13.2.2. Electrophysiology Diagnostic Catheters; 13.2.2.1. Conventional Electrophysiology Diagnostic Catheters; 13.2.2.1.1. Steerable Diagnostic Catheters; 13.2.2.1.2. Fixed Diagnostic Catheters; 13.2.2.2. Advanced Electrophysiology Diagnostic Catheters; 13.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 13.2.3. Electrophysiology Laboratory Devices; 13.2.4. Access Devices; 13.2.5. Others; 13.3. Market Value Forecast, by End-user, 2017–2031; 13.3.1. Hospitals; 13.3.2. Diagnostic Centers; 13.3.3. Clinics; 13.3.4. Others; 13.4. Market Value Forecast, by Indication, 2017–2031; 13.4.1. Atrial Fibrillation (AF); 13.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 13.4.3. Wolff-Parkinson-White Syndrome (WPW); 13.4.4. Atrial Flutter; 13.4.5. Others; 13.5. Market Value Forecast, by Country/Sub-region, 2017–2031; 13.5.1. Brazil; 13.5.2. Mexico; 13.5.3. Rest of Latin America; 13.6. Market Attractiveness Analysis; 13.6.1. By Product Type; 13.6.2. By End-user; 13.6.3. By Indication; 13.6.4. By Country/Sub-region
14. Middle East & Africa Electrophysiology Devices Market Analysis and Forecast: 14.1. Introduction; 14.1.1. Key Findings; 14.2. Market Value Forecast, by Product Type, 2017–2031; 14.2.1. Electrophysiology Ablation Catheters; 14.2.1.1. Cryoablation Electrophysiology Catheters; 14.2.1.2. Radiofrequency Ablation Catheters; 14.2.1.2.1. Irrigated-tip Radiofrequency Ablation Catheters; 14.2.1.2.2. Conventional Radiofrequency Ablation Catheters; 14.2.1.3. Laser Ablation Systems; 14.2.1.4. Microwave Ablation Systems; 14.2.1.5. Navigational Advanced Mapping Accessories; 14.2.2. Electrophysiology Diagnostic Catheters; 14.2.2.1. Conventional Electrophysiology Diagnostic Catheters; 14.2.2.1.1. Steerable Diagnostic Catheters; 14.2.2.1.2. Fixed Diagnostic Catheters; 14.2.2.2. Advanced Electrophysiology Diagnostic Catheters; 14.2.2.3. Ultrasound Electrophysiology Diagnostic Catheters; 14.2.3. Electrophysiology Laboratory Devices; 14.2.4. Access Devices; 14.2.5. Others; 14.3. Market Value Forecast, by End-user, 2017–2031; 14.3.1. Hospitals; 14.3.2. Diagnostic Centers; 14.3.3. Clinics; 14.3.4. Others; 14.4. Market Value Forecast, by Indication, 2017–2031; 14.4.1. Atrial Fibrillation (AF); 14.4.2. Atrioventricular Nodal Reentry Tachycardia (AVNRT); 14.4.3. Wolff-Parkinson-White Syndrome (WPW); 14.4.4. Atrial Flutter; 14.4.5. Others; 14.5. Market Value Forecast, by Country/Sub-region, 2017–2031; 14.5.1. GCC Countries; 14.5.2. South Africa; 14.5.3. Rest of Middle East & Africa; 14.6. Market Attractiveness Analysis; 14.6.1. By Product Type; 14.6.2. By End-user; 14.6.3. By Indication; 14.6.4. By Country/Sub-region
15. Competition Landscape: 15.1. Market Player - Competition Matrix (by tier and size of companies); 15.2. Market Share Analysis, by Company, 2021; 15.3. Company Profiles; 15.3.1. Abbott Laboratories; 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.1.2. Product Portfolio; 15.3.1.3. SWOT Analysis; 15.3.1.4. Strategic Overview; 15.3.2. Acutus Medical, Inc.; 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.2.2. Product Portfolio; 15.3.2.3. SWOT Analysis; 15.3.2.4. Strategic Overview; 15.3.3. F. Siemens AG; 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.3.2. Product Portfolio; 15.3.3.3. SWOT Analysis; 15.3.3.4. Strategic Overview; 15.3.4. Nihon Kohden Corporation; 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.4.2. Product Portfolio; 15.3.4.3. SWOT Analysis; 15.3.4.4. Strategic Overview; 15.3.5. Biosense Webster, Inc.; 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.5.2. Product Portfolio; 15.3.5.3. SWOT Analysis; 15.3.5.4. Strategic Overview; 15.3.6. Boston Scientific Corporation; 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.6.2. Product Portfolio; 15.3.6.3. SWOT Analysis; 15.3.6.4. Strategic Overview; 15.3.7. GE Healthcare; 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.7.2. Product Portfolio; 15.3.7.3. SWOT Analysis; 15.3.7.4. Strategic Overview; 15.3.8. Medtronic plc; 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.8.2. Product Portfolio; 15.3.8.3. SWOT Analysis; 15.3.8.4. Strategic Overview; 15.3.9. Koninklijke Philips N.V.; 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.9.2. Product Portfolio; 15.3.9.3. SWOT Analysis; 15.3.9.4. Strategic Overview; 15.3.10. Biotronik SE & Co.KG; 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.10.2. Product Portfolio; 15.3.10.3. SWOT Analysis; 15.3.10.4. Strategic Overview; 15.3.11. Microport Scientific Corporation; 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength); 15.3.11.2. Product Portfolio; 15.3.11.3. SWOT Analysis; 15.3.11.4. Strategic Overview; 15.3.12. Other Player